Orion Infusions (DHA:ORIONINFU) Days Sales Outstanding : 61.04 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Days Sales Outstanding?

Orion Infusions's average Accounts Receivable for the three months ended in Dec. 2023 was BDT135.6 Mil. Orion Infusions's Revenue for the three months ended in Dec. 2023 was BDT202.7 Mil. Hence, Orion Infusions's Days Sales Outstanding for the three months ended in Dec. 2023 was 61.04.

The historical rank and industry rank for Orion Infusions's Days Sales Outstanding or its related term are showing as below:

DHA:ORIONINFU' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.4 Med: 67.92 Max: 84.71
Current: 61.89

During the past 13 years, Orion Infusions's highest Days Sales Outstanding was 84.71. The lowest was 52.40. And the median was 67.92.

DHA:ORIONINFU's Days Sales Outstanding is ranked better than
60.16% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.38 vs DHA:ORIONINFU: 61.89

Orion Infusions's Days Sales Outstanding declined from Dec. 2022 (68.20) to Dec. 2023 (61.04).

Orion Infusions Days Sales Outstanding Historical Data

The historical data trend for Orion Infusions's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Days Sales Outstanding Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

64.66

82.63

84.71

63.66

63.12

Orion Infusions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															68.20	73.73	62.44	51.83	61.04

Competitive Comparison of Orion Infusions's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Infusions's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Orion Infusions's Days Sales Outstanding falls into.

Orion Infusions Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Orion Infusions's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (148.347	+	131.867)	/	2 )	/	810.153	*	365
=	140.107					/	810.153	*	365
=	63.12

Orion Infusions's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (136.054	+	135.18)	/	2 )	/	202.732	*	365 / 4
=	135.617					/	202.732	*	365 / 4
=	61.04

Orion Infusions (DHA:ORIONINFU) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Orion Infusions Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines